Perspectives on Follicular Lymphoma Treatment From New and Experienced Clinicians: New, Old, & Old Is New

Journal article

Open access

Peer reviewed

Jonathan R Day and Brian K Link

Oncology (Williston Park, N.Y.), Vol.36(2), pp.100-101

02/08/2022

DOI: 10.46883/2022.25920947

PMID: 35180335

Files and links (1)

url

https://doi.org/10.46883/2022.25920947View

Published (Version of record) Open Access

Jonathan R. Day, MD, PharmD, and Brian K. Link, MD, give their perspective on emerging treatments for follicular lymphoma.

Antibodies, Monoclonal - therapeutic use

Antineoplastic Agents, Immunological - therapeutic use

Humans

Immunotherapy, Adoptive

Lymphoma, Follicular - therapy

Molecular Targeted Therapy

Protein Kinase Inhibitors - therapeutic use

Title: Subtitle: Perspectives on Follicular Lymphoma Treatment From New and Experienced Clinicians: New, Old, & Old Is New
Creators: Jonathan R Day
Brian K Link
Resource Type: Journal article
Publication Details: Oncology (Williston Park, N.Y.), Vol.36(2), pp.100-101
DOI: 10.46883/2022.25920947
PMID: 35180335
ISSN: 0890-9091
eISSN: 2767-7389
Grant note: R38 HL150208 / NHLBI NIH HHS
Language: English
Date published: 02/08/2022
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984359573002771

17 Record Views